Comparative effects of sirolimus-eluting versus bare metal stents on neointimal hyperplasia in balloon-injured external iliac artery of rabbits
The aim of this study was to check effectiveness of drug-eluting stents for prevention of restenosis resulting from neointimal hyperplasia. Twenty-one sirolimus-eluting stents (SESs) and bare metal stents (BMSs; control) were compared by implantation into left and right balloon-injured external iliac arteries of New Zealand White rabbits, respectively. Under general anesthesia and angiography, using 3-mm coronary balloon catheters, stents were successfully deployed. Anticoagulant therapy was not given to any animal. Rabbits were allotted into three groups at 7, 14, and 21 days (7 rabbits in each group). Each stented vessel of sacrificed rabbits was subjected to a resin-embedding technique and methyl methacrylate sections were obtained using a tungsten carbide knife for staining. In histological examination, SESs showed marked reductions in almost all parameters. Morphometric results showed that arteries with SESs had a larger luminal area (P < 0.0001), lower intimal (P < 0.001) and medial (P < 0.001) thickness, and lower intimal index (P < 0.003) as opposed to arteries stented with BMSs. Luminal narrowing in SESs was 0% and reendothelialization was similar in both stented groups (90.48%). SESs showed marked reduction in nonocclusive peristrut fibrin deposition versus BMSs. Thus, the SES was more effective for prevention of restenosis than the BMS in rabbit.
Comparative effects of sirolimus-eluting versus bare metal stents on neointimal hyperplasia in balloon-injured external iliac artery of rabbits
The aim of this study was to check effectiveness of drug-eluting stents for prevention of restenosis resulting from neointimal hyperplasia. Twenty-one sirolimus-eluting stents (SESs) and bare metal stents (BMSs; control) were compared by implantation into left and right balloon-injured external iliac arteries of New Zealand White rabbits, respectively. Under general anesthesia and angiography, using 3-mm coronary balloon catheters, stents were successfully deployed. Anticoagulant therapy was not given to any animal. Rabbits were allotted into three groups at 7, 14, and 21 days (7 rabbits in each group). Each stented vessel of sacrificed rabbits was subjected to a resin-embedding technique and methyl methacrylate sections were obtained using a tungsten carbide knife for staining. In histological examination, SESs showed marked reductions in almost all parameters. Morphometric results showed that arteries with SESs had a larger luminal area (P < 0.0001), lower intimal (P < 0.001) and medial (P < 0.001) thickness, and lower intimal index (P < 0.003) as opposed to arteries stented with BMSs. Luminal narrowing in SESs was 0% and reendothelialization was similar in both stented groups (90.48%). SESs showed marked reduction in nonocclusive peristrut fibrin deposition versus BMSs. Thus, the SES was more effective for prevention of restenosis than the BMS in rabbit.
___
- Assali AR, Moustapha A, Sdringola S, Denktas AE, Willerson JT, Holmes DR Jr, Smalling RW. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (The PRESTO trial). Am J Cardiol 2006; 98: 729–733.
- Bennett MR, O’Sullivan M. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Pharmacol Ther 2001; 91: 149–166.
- Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974–2980.
- Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496– 501.
- Kobayashi Y, De GJ, Kobayashi N. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999; 34: 651–659.
- Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991; 17: 758–769.
- David RH, Brian GF, Douglas LW. Paradigm shifts in cardiovascular medicine. J Am Coll Cardiol 2004; 43: 507–512.
- Steffel J, Tanner FC. Biological effects of drug-eluting stents in the coronary circulation. Herz 2007; 32: 268–273.
- Iijima R, Mehilli J, Schomig A, Kastrati A. Clinical evidence on polymer- based sirolimus and paclitaxel eluting stents. Minerva Cardioangiol 2006; 54: 539–555.
- Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O’Shaughnessy CD, DeMaio S, Hall P, Popma JJ et al. Comparison of a polymer based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005; 294: 1215– 1223.
- Virmani R, Kolodgie FD, Farb A, Lafout A. Drug eluting stents: are human and animal studies comparable? Heart 2003; 89: 133–138.
- Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, Scott DS, Froehlich J, Virmani R. Pathological analysis of local delivery of paclitaxel via polymer-coated stents. Circulation 2001; 104: 473–479.
- LaDisa JF Jr, Meier HT, Olson LE, Kersten JR, Warltier DC, Pagel PS. Antegrade iliac artery stent implantation for the temporal and spatial examination of stent-induced neointimal hyperplasia and alterations in regional fluid dynamics. J Pharmacol Toxicol Methods 2005; 51: 115–121.
- Anderson TJ, Meredith IT, Uehata A, Mudge GH, Selwyn AP, Ganz P, Yeung AC. Functional significance of intimal thickness and detected by intravascular ultrasound early and late cardiac transplantation. Circular 1993; 88: 1093–1100.
- Klugherz BD, Llanos G, Lieuallen W, Kopia GA, Papandreou G, Narayan P, Sasseen B, Adelman SJ, Falotico R, Wilensky RL. Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent. Coron Artery Dis 2002; 13: 183–188.
- Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky RL, Klugherz BD. Stent based delivery of sirolimus reduces neointimal formation in porcine coronary model. Circulation 2001; 104: 1188–1193.
- Villa A, Arnold R, Sánchez PL, Gimeno F, Ramos B, Cantero T, Fernández ME, Sanz R, Gutiérrez O, Mota P et al. Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone- marrow mononuclear cell transplantation following acute myocardial infarction. Am J Cardiol 2009; 103: 1651–1656.
- Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular response to drug eluting stents. Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500–1510.
- Sun J, Marx SO, Chen H, Poon M, Marks AR, Rabbani LE. Role for p27Kip1 in vascular smooth muscle cell migration. Circulation 2001; 103: 2967–2972.
- Costa MA, Simon DI. Molecular basis of restenosis and drug eluting stents. Circulation 2005; 111: 2257–2273.
- Chen Z, Keaney JF, Schulz E, Levison B, Shah L, Sakuma M, Zhang X, Shi C, Hazen SL, Simon DI. Decreased neointimal formation in Nox-2 deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury. P Natl Acad Sci USA 2004; 101: 13014–13019.
- Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. Expression and secretion of type beta transforming growth factors by activated human macrophages. P Natl Acad Sci USA 1987; 84: 6020–6021.
- Sukhova GK, Sui GP, Simon DI, Chapman HA, Libby P. Expression of the elastinolytic cathepsins S and K in human atheroma and regulation of their production in the smooth muscle cells. J Clin Invest 1998; 102: 576–583.
- Frey D, Billinger M, Meier P, Beslac O, Grossenbacher R, Hanni B, Hess OM. Endothelialization of sirolimus eluting stents with slow and extended drug release in porcine overstretch model. J Invasive Cardiol 2008; 20: 631–634.
- Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 2005; 111: 926–931.
- Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus- eluting stents with bare metal stents. N Engl J Med 2007; 356: 989–997.